Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Dec 1;352(Pt 2):287–292.

The ornithine decarboxylase domain of the bifunctional ornithine decarboxylase/S-adenosylmethionine decarboxylase of Plasmodium falciparum: recombinant expression and catalytic properties of two different constructs.

T Krause 1, K Lüersen 1, C Wrenger 1, T W Gilberger 1, S Müller 1, R D Walter 1
PMCID: PMC1221458  PMID: 11085920

Abstract

The polyamines putrescine, spermidine and spermine play an essential role in cell differentiation and proliferation. Inhibition of the rate-limiting enzymes of polyamine biosynthesis, ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (AdoMetDC), has been proposed as a therapeutic strategy against cancer and parasitic infections. In the case of Plasmodium falciparum, the causative agent of malaria tropica, this approach is especially interesting, because here both key enzymes, ODC and AdoMetDC, are combined in a bifunctional protein, ODC/AdoMetDC. This arrangement has not been found in any other organism investigated so far. We report the cloning and recombinant expression of the ODC domain of P. falciparum in Escherichia coli. First, we expressed the mere recombinant ODC domain (rPfODC). Secondly, we expressed the recombinant ODC domain in conjunction with the preceding part of the hinge region of the bifunctional ODC/AdoMetDC (rPfHinge-ODC). K(m) values for L-ornithine were 47.3 microM for the rPfHinge-ODC and 161. 5 microM for the rPfODC. Both recombinant enzymes were inhibited by putrescine, but the K(i) value for the rPfHinge-ODC was 50.4 microM (IC(50)=157 microM), whereas the IC(50) for the rPfODC was 500 microM. Spermidine was a weak inhibitor in both cases. alpha-Difluoromethylornithine inhibited the rPfHinge-ODC with a K(i) value of 87.6 microM. For two novel ODC inhibitors, CGP52622A and CGP54619A, the K(i) values of the rPfHinge-ODC were in the nanomolar range.

Full Text

The Full Text of this article is available as a PDF (141.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assaraf Y. G., Golenser J., Spira D. T., Bachrach U. Polyamine levels and the activity of their biosynthetic enzymes in human erythrocytes infected with the malarial parasite, Plasmodium falciparum. Biochem J. 1984 Sep 15;222(3):815–819. doi: 10.1042/bj2220815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bacchi C. J. Content, synthesis, and function of polyamines in trypanosomatids: relationship to chemotherapy. J Protozool. 1981 Feb;28(1):20–27. doi: 10.1111/j.1550-7408.1981.tb02798.x. [DOI] [PubMed] [Google Scholar]
  3. Barnett G. R., Kazarinoff M. N. Purification and properties of ornithine decarboxylase from Physarum polycephalum. J Biol Chem. 1984 Jan 10;259(1):179–183. [PubMed] [Google Scholar]
  4. Bitonti A. J., McCann P. P., Sjoerdsma A. Plasmodium falciparum and Plasmodium berghei: effects of ornithine decarboxylase inhibitors on erythrocytic schizogony. Exp Parasitol. 1987 Oct;64(2):237–243. doi: 10.1016/0014-4894(87)90148-2. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  6. Bzik D. J., Li W. B., Horii T., Inselburg J. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8360–8364. doi: 10.1073/pnas.84.23.8360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carucci D. J., Witney A. A., Muhia D. K., Warhurst D. C., Schaap P., Meima M., Li J. L., Taylor M. C., Kelly J. M., Baker D. A. Guanylyl cyclase activity associated with putative bifunctional integral membrane proteins in Plasmodium falciparum. J Biol Chem. 2000 Jul 21;275(29):22147–22156. doi: 10.1074/jbc.M001021200. [DOI] [PubMed] [Google Scholar]
  8. Clos J., Brandau S. pJC20 and pJC40--two high-copy-number vectors for T7 RNA polymerase-dependent expression of recombinant genes in Escherichia coli. Protein Expr Purif. 1994 Apr;5(2):133–137. doi: 10.1006/prep.1994.1020. [DOI] [PubMed] [Google Scholar]
  9. DiGangi J. J., Seyfzadeh M., Davis R. H. Ornithine decarboxylase from Neurospora crassa. Purification, characterization, and regulation by inactivation. J Biol Chem. 1987 Jun 5;262(16):7889–7893. [PubMed] [Google Scholar]
  10. Fairlamb A. H., Henderson G. B., Bacchi C. J., Cerami A. In vivo effects of difluoromethylornithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol. 1987 Jun;24(2):185–191. doi: 10.1016/0166-6851(87)90105-8. [DOI] [PubMed] [Google Scholar]
  11. Fonzi W. A., Sypherd P. S. The gene and the primary structure of ornithine decarboxylase from Saccharomyces cerevisiae. J Biol Chem. 1987 Jul 25;262(21):10127–10133. [PubMed] [Google Scholar]
  12. Hanson S., Adelman J., Ullman B. Amplification and molecular cloning of the ornithine decarboxylase gene of Leishmania donovani. J Biol Chem. 1992 Feb 5;267(4):2350–2359. [PubMed] [Google Scholar]
  13. Heby O. Ornithine decarboxylase as target of chemotherapy. Adv Enzyme Regul. 1985;24:103–124. doi: 10.1016/0065-2571(85)90072-x. [DOI] [PubMed] [Google Scholar]
  14. Henderson P. J. A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem J. 1972 Apr;127(2):321–333. doi: 10.1042/bj1270321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hollingdale M. R., McCann P. P., Sjoerdsma A. Plasmodium berghei: inhibitors of ornithine decarboxylase block exoerythrocytic schizogony. Exp Parasitol. 1985 Aug;60(1):111–117. doi: 10.1016/s0014-4894(85)80028-x. [DOI] [PubMed] [Google Scholar]
  16. Jänne J., Alhonen L., Leinonen P. Polyamines: from molecular biology to clinical applications. Ann Med. 1991 Aug;23(3):241–259. doi: 10.3109/07853899109148056. [DOI] [PubMed] [Google Scholar]
  17. KITZ R., WILSON I. B. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem. 1962 Oct;237:3245–3249. [PubMed] [Google Scholar]
  18. Kitani T., Fujisawa H. Purification and properties of ornithine decarboxylase from rat liver. J Biol Chem. 1983 Jan 10;258(1):235–239. [PubMed] [Google Scholar]
  19. Marton L. J., Pegg A. E. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol. 1995;35:55–91. doi: 10.1146/annurev.pa.35.040195.000415. [DOI] [PubMed] [Google Scholar]
  20. Mett H., Stanek J., Lopez-Ballester J. A., Jänne J., Alhonen L., Sinervirta R., Frei J., Regenass U. Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analogues. Cancer Chemother Pharmacol. 1993;32(1):39–45. doi: 10.1007/BF00685874. [DOI] [PubMed] [Google Scholar]
  21. Müller S., Da'dara A., Lüersen K., Wrenger C., Das Gupta R., Madhubala R., Walter R. D. In the human malaria parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase. J Biol Chem. 2000 Mar 17;275(11):8097–8102. doi: 10.1074/jbc.275.11.8097. [DOI] [PubMed] [Google Scholar]
  22. Newton P., White N. Malaria: new developments in treatment and prevention. Annu Rev Med. 1999;50:179–192. doi: 10.1146/annurev.med.50.1.179. [DOI] [PubMed] [Google Scholar]
  23. Niemann G., von Besser H., Walter R. D. Panagrellus redivivus ornithine decarboxylase: structure of the gene, expression in Escherichia coli and characterization of the recombinant protein. Biochem J. 1996 Jul 1;317(Pt 1):135–140. doi: 10.1042/bj3170135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Osterman A. L., Kinch L. N., Grishin N. V., Phillips M. A. Acidic residues important for substrate binding and cofactor reactivity in eukaryotic ornithine decarboxylase identified by alanine scanning mutagenesis. J Biol Chem. 1995 May 19;270(20):11797–11802. doi: 10.1074/jbc.270.20.11797. [DOI] [PubMed] [Google Scholar]
  25. Phillips M. A., Coffino P., Wang C. C. Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei. Implications for enzyme turnover and selective difluoromethylornithine inhibition. J Biol Chem. 1987 Jun 25;262(18):8721–8727. [PubMed] [Google Scholar]
  26. Phillips M. A., Coffino P., Wang C. C. Trypanosoma brucei ornithine decarboxylase: enzyme purification, characterization, and expression in Escherichia coli. J Biol Chem. 1988 Dec 5;263(34):17933–17941. [PubMed] [Google Scholar]
  27. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schaeffer J. M., Donatelli M. R. Characterization of a high-affinity membrane-associated ornithine decarboxylase from the free-living nematode Caenorhabditis elegans. Biochem J. 1990 Sep 15;270(3):599–604. doi: 10.1042/bj2700599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Seiler N., Heby O. Regulation of cellular polyamines in mammals. Acta Biochim Biophys Hung. 1988;23(1):1–35. [PubMed] [Google Scholar]
  30. Shallom S., Zhang K., Jiang L., Rathod P. K. Essential protein-protein interactions between Plasmodium falciparum thymidylate synthase and dihydrofolate reductase domains. J Biol Chem. 1999 Dec 31;274(53):37781–37786. doi: 10.1074/jbc.274.53.37781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stanek J., Frei J., Mett H., Schneider P., Regenass U. 2-substituted 3-(aminooxy)propanamines as inhibitors of ornithine decarboxylase: synthesis and biological activity. J Med Chem. 1992 Apr 17;35(8):1339–1344. doi: 10.1021/jm00086a003. [DOI] [PubMed] [Google Scholar]
  32. Triglia T., Cowman A. F. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7149–7153. doi: 10.1073/pnas.91.15.7149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tyagi A. K., Tabor C. W., Tabor H. Ornithine decarboxylase from Saccharomyces cerevisiae. Purification, properties, and regulation of activity. J Biol Chem. 1981 Dec 10;256(23):12156–12163. [PubMed] [Google Scholar]
  34. Van Nieuwenhove S., Schechter P. J., Declercq J., Boné G., Burke J., Sjoerdsma A. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial. Trans R Soc Trop Med Hyg. 1985;79(5):692–698. doi: 10.1016/0035-9203(85)90195-6. [DOI] [PubMed] [Google Scholar]
  35. Yarlett N., Goldberg B., Moharrami M. A., Bacchi C. J. Trichomonas vaginalis: characterization of ornithine decarboxylase. Biochem J. 1993 Jul 15;293(Pt 2):487–493. doi: 10.1042/bj2930487. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES